The Intelligent Manufacturing in China Serum-free Culture Medium Makes A Stunning Appearance At Biocon

 

On September 8, 2022, BioCon Expo 2022, the 9th International Biopharmaceutical Conference and Exhibition, came to a successful conclusion at Hangzhou International Expo Center, and BioEngine presented its innovative large-scale cell culture technology and media products at the event.

Let's review the wonderful moments of BioEngine during BioCon!

Special lectures

Prof. Wensong Tan, Chairman of BioEngine, was invited to participate in the roundtable discussion and delivered a special report on the localization of serum-free culture medium, enabling China's biopharmaceutical industry to reduce costs and increase efficiency. He led the audience to review the breakthrough progress of animal cell mass culture technology in the past 30 years, analyze its core technology issues, and discuss the road of "Intelligent Manufacturing in China" of serum-free culture medium with BioEngine as an example.

 

 

Prof. Wensong Tan participated in the roundtable discussion

 

 

Prof. Wensong Tan gave a special report

 

 

Dr. Li Fan, Senior Vice President of BioEngine, delivered a presentation at the Antibody Protein Drug Process Forum: Cell Culture Process Development and Upgrading Guide - Case Sharing. He shared with the audience the golden key to cell culture process development and upgrading. Only "China Smart" with data analysis and kinetics can effectively help us to analyze the process of cell culture, truly realize the process upgrading and create value for customers.

 

 

Dr. Li Fan gave a presentation

 

 

Communication in booth

In just two days, there were a lot of attendees coming to the BioEngine booth B11, including not only the old customers who have reached long-term friendly cooperation but also many new friends who are interested in the "Intelligent Manufacturing in China" serum-free medium.

 

 

Through on-site technical explanation and Q&A, more new and old customers have a further understanding of "Intelligent Manufacturing in China" serum-free media, which laid the foundation for further discussion and cooperation.

 

 

BioCon has come to a successful end, and in the future, BioEngine will continue to make breakthroughs and surpass the original intention with craftsmanship, to be a trustworthy partner for animal cell culture and to help accelerate the biopharmaceutical industry.